(Q46128313)
Statements
Safety and tolerability of ferric carboxymaltose (FCM) for treatment of iron deficiency in patients with chronic kidney disease and in kidney transplant recipients (English)
A-C Grimmelt
C D Cohen
T Fehr
A L Serra
scientific article published in February 2009